ATC J07BX - Other viral vaccines - Spain

ABRYSVO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Form: powder and solvent for solution for injection

Active substance	Dosage
respiratory syncytial virus, subgroup a, f protein subunit 847a stabilized in prefusion	0,06 mg
respiratory syncytial virus, subgroup b, f protein subunit 847b stabilized in prefusion	0,06 mg

ATC code: J07B, J07BX, J07BX05

Form: powder and suspension for injectable suspension

Active substance	Dosage
vaccine (rsvpref) of stabilized f subunit in prefusion against respiratory syncytial virus	120 µg

ATC code: J07B, J07BX, J07BX05

Form: solution for injection

Active substance	Dosage
mrna vaccine encoding the viral spike s protein of sars-cov-2 omicron lp.8.1	10 µg

ATC code: J07B, J07BX

Form: solution for injection, concentrate

Active substance	Dosage
mrna vaccine encoding the viral spike s protein of sars-cov-2 omicron lp.8.1	3 µg

ATC code: J07B, J07BX

Form: solution for injection

Active substance	Dosage
mrna vaccine encoding the viral spike s protein of sars-cov-2 omicron lp.8.1	30 µg

ATC code: J07B, J07BX

Form: powder and solvent for solution for injection

Active substance	Dosage
dengue virus live attenuated serotype 1	≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
dengue virus live attenuated serotype 2	≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
dengue virus live attenuated serotype 3	≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
dengue virus live attenuated serotype 4	≥ 4,5 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)

ATC code: J07B, J07BX, J07BX04

Manufacturer: Takeda Gmbh